Chargement en cours...
Making wider use of the world's most widely used vaccine: Bacille Calmette–Guérin revaccination reconsidered
Approximately 100 million newborn children receive Bacille Calmette–Guérin (BCG) annually, because vaccination is consistently protective against childhood tuberculous meningitis and miliary TB. By contrast, BCG efficacy against pulmonary TB in children and adults is highly variable, ranging from 0%...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Royal Society
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3757998/ https://ncbi.nlm.nih.gov/pubmed/23904584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rsif.2013.0365 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|